Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00197067
Status:
COMPLETED
Last Update Posted:
2019-12-27
First Post:
2005-09-13
Brief Title:
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals Candidate Vaccines RTSSAS02D 05 mL Dose and RTSSAS02A 025 mL Dose Administered IM According to a 0 1 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Malaria |
Keywords: